title: Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia.
abstract: In unrelated cord blood (UCB) transplantation, survival has been shown to correlate with the degree of HLA matching. Thus, to extend transplant access to different ethnic backgrounds, many western UCB transplantation banks now encourage donation from non-Caucasians. Until recently, Saudi Arabia did not have a national UCB bank. In this study we report our experience in UCB transplantation in children using units procured from western cord blood banks. A total of 97 children underwent unrelated UCB transplantation at King Faisal Specialist Hospital and Research Center (KFSHRC), of which 95 were of Arab ethnicity. A total of 30 patients had malignant disorders, 25 patients had non-malignant hematological disorders and 42 patients had inborn errors. Conditioning was according to disease, with six patients receiving reduced-intensity regimens. In all, 46 patients received one-Ag-mismatched units and 51 received two-Ag-mismatched units. Engraftment occurred in 93% of patients, the 100-TRM was 15%, acute GVHD developed in 20% of patients and chronic GVHD occurred in 9% of patients. The 5-year OS and EFS estimates were 52 and 43%, respectively. The search for UCB transplantation units for Saudi patients in western banks yielded reasonably compatible units for our patients; the results are consistent with published data. Our data are encouraging for UCB transplant programs in countries in which there are no national UCB transplantation banks.
authors.affiliation: Section of Pediatric Stem Cell Transplantation, Department of Pediatric Hematology-Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. mouhab@kfshrc.edu.sa
authors.forename: M
authors.initials: M
authors.lastname: Ayas
authors.forename: A
authors.initials: A
authors.lastname: Al-Seraihi
authors.forename: A
authors.initials: A
authors.lastname: Al-Jefri
authors.forename: A
authors.initials: A
authors.lastname: Al-Ahmari
authors.forename: M
authors.initials: M
authors.lastname: Al-Mahr
authors.forename: A
authors.initials: A
authors.lastname: Al-Ghonaium
authors.forename: S
authors.initials: S
authors.lastname: Al-Muhsen
authors.forename: H
authors.initials: H
authors.lastname: Al-Mousa
authors.forename: H
authors.initials: H
authors.lastname: Al-Dhekri
authors.forename: B
authors.initials: B
authors.lastname: Alsaud
authors.forename: A
authors.initials: A
authors.lastname: Eldali
authors.forename: A
authors.initials: A
authors.lastname: Mohamad
authors.forename: H
authors.initials: H
authors.lastname: Al-Humaidan
authors.forename: A
authors.initials: A
authors.lastname: Chadrawi
authors.forename: M
authors.initials: M
authors.lastname: Al-Kaff
authors.forename: Z
authors.initials: Z
authors.lastname: Al-Hassnan
authors.forename: H
authors.initials: H
authors.lastname: El-Solh
mesh_terms: D000094902:Blood Banking / Q000379:methods*; D001782:Blood Donors / Q000600:supply & distribution*; D002648:Child; D002675:Child, Preschool; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D005006:Ethnicity; D005260:Female; D030342:Genetic Diseases, Inborn / Q000628:therapy; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000209:etiology; D006402:Hematologic Diseases / Q000453:epidemiology / Q000628:therapy; D006650:Histocompatibility Testing; D006801:Humans; D007223:Infant; D007391:International Cooperation; D008297:Male; D012529:Saudi Arabia; D014181:Transplantation Immunology